Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
15 p.
item.page.accessRights
Acceso abierto
item.page.other
item.page.references
Abstract
Background: Chile has achieved the highest coverage for vaccines against the SARS-CoV-2 virus worldwide. Objective: To assess the progression of immunity (natural and acquired by vaccine) in a cohort ...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Ramírez-Santana, M.; Rubilar, P.; Vial, C.; Apablaza, M.; González, C.; Said, M.; Olivares, K.; Cortés, L.J.; Hormazábal, J.; et al. Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022. Viruses 2023, 15, 201. https://doi.org/10.3390/ v15010201
Keywords
seroprevalence , Seroepidemiology , Covid-19 , Vaccines , Immunity , Antibodies , Chile
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026